NasdaqGS:JAZZPharmaceuticals
Jazz Pharmaceuticals (JAZZ) Stock Looks Cheap On Earnings While Broader Checks Stay Mixed
Jazz Pharmaceuticals stock has more than doubled over the past year, yet current market multiples still suggest the shares may be pricing in less optimism than the recent performance and deal activity might imply.
The share price has returned 112.6% over the last 12 months, which raises the question of how much of Jazz Pharmaceuticals' recent momentum is already reflected in today’s valuation.
Investors are weighing the potential value from the planned Actio Biosciences acquisition and an...